Nuclear Receptor Subfamily 0, Group B, Member 1 (NR0B1) Peptide
NR0B1
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits NR0B1
- NR0B1 (Nuclear Receptor Subfamily 0, Group B, Member 1 (NR0B1))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- DAX1 peptide corresponds to 13 amino acids of DAX1.
-
-
- Indications d'application
- DAX1 Peptide is used for blocking the activity of DAX1 antibody . The DAX1 antibody ships at 0.5 mg/mL and the DAX1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- DAX1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- NR0B1 (Nuclear Receptor Subfamily 0, Group B, Member 1 (NR0B1))
- Synonymes
- DAX Peptide, NR0B1 Peptide, dax1 Peptide, AHC Peptide, AHCH Peptide, AHX Peptide, DAX-1 Peptide, DAX1 Peptide, DSS Peptide, GTD Peptide, HHG Peptide, NROB1 Peptide, SRXY2 Peptide, Ahc Peptide, Ahch Peptide, Dax1 Peptide, nuclear receptor subfamily 0 group B member 1 Peptide, nuclear receptor subfamily 0, group B, member 1 Peptide, nuclear receptor subfamily 0 group B member 1 L homeolog Peptide, NR0B1 Peptide, nr0b1 Peptide, nr0b1.L Peptide, Nr0b1 Peptide
- ID gène
- 190
- NCBI Accession
- NP_000466
- OMIM
- 5016090
- UniProt
- P51843
-
Vous êtes ici:
